BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Fluoxetine
,
rs2476601
,
DRD2
,
T cell differentiation
,
Pseudomonas infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RCCs
Summary
General Info
Curated Studies
Most Correlated Studies
Kidney cancer RCC-4 cells with or without VHL expression and deprived of cystine
Renal carcinoma RCC-4 cells VHL null or wildtype; effects of exposure to hypoxia
Clear cell renal carcinoma RCC4 cells with TAZ siRNA knockdown treated with erastin
Renal cell carcinoma (RCC) and healthy CD8+ T cells stimulated with RCC cells
Pulmonary metastases and primary tumors of clear-cell RCC with different disease-free survivals
Explore Curated Studies Results
Literature
Most Relevant Literature
Polβ/XRCC1 heterodimerization dictates DNA damage recognition and basal Polβ protein levels without …
X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone -induced apoptosis in p…
RAD52 Adjusts Repair of Single-Strand Breaks via Reducing DNA-Damage-Promoted XRCC1/LIG3α Co-localiz…
XRCC1 phosphorylation affects aprataxin recruitment and DNA deadenylation activity.
PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand brea…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Assessment of QoL and Outcomes With SBRT for RCC
Surgical Treatment of Pancreatic RCC Metastases
Biomarkers of Response to Systemic Treatments in FH-deficient RCC
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for …
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ